22157.jpg
COVID-19 Pandemic Mitigation Products Market Worth $1.9 Trillion by 2024 - A Thorough Industry Analysis of 54 Products & Services, 6 Vertical, 4 Revenue Source, 5 Regional & 13 National Markets
January 07, 2021 11:28 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Pandemic Mitigation Products Market - 2020-2024" report has been added to ResearchAndMarkets.com's offering. According to the report, the...
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
December 01, 2020 10:15 ET | Codex
San Diego, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and...
22157.jpg
COVID-19 Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances Analysis: A Round-up of Crucial Developments
October 27, 2020 05:23 ET | Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances - Comprehensive Bundle" report has been added to...
GOVX new logo.png
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
October 26, 2020 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
22157.jpg
Global Influenza Vaccines Markets Report 2020: Quadrivalent is the Dominant Type of Influenza Vaccine - Forecast to 2028
October 01, 2020 04:49 ET | Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global influenza vaccines market is...
22157.jpg
COVID-19 Vaccine Developments: 6 Daily Updates, 6 Weekly Summary Reports, 6 Monthly Synthesis Reports
September 15, 2020 05:38 ET | Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle" report has been added to...
22157.jpg
COVID-19 Vaccine Reporting Subscription: Development, Therapeutics Experiments and Diagnostics/Devices Advances
September 10, 2020 10:58 ET | Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances - Basic Bundle" report has been added to...
22157.jpg
US Influenza Vaccines Market Size and Analysis 2020: Clinical Trial Insights by Phase, Company and Country
September 04, 2020 06:34 ET | Research and Markets
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Forecast 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The United States...
22157.jpg
COVID-19 Mitigation Products Market Outlook 2020-2024 - Forecast to Reach $1.6 Trillion (Scenario A); $2.2 Trillion (Scenario B), with Insights Into 248 Sub-Markets
August 31, 2020 04:44 ET | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Mitigation Products: Market Research, to 2024" report has been added to ResearchAndMarkets.com's offering. On the backdrop of the global...
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
August 25, 2020 10:24 ET | Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...